Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413212
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-01-14
Brief Title:
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Sponsor:
Liu Huang
Organization:
Tongji Hospital
Study Overview
Official Title:
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To explore the consistency between result of PTC drug screening tests and actual clinical outcome for patients with advanced malignancy
Detailed Description:
This study is anticipated to enroll 55 patients with advanced malignancy and fresh malignant effusion samples collected from patients would be detected by PTC drug screening In addition patients would receive 2 cycles of personal therapy based on results of screening tests By combining PTC drug sensitivity results with patients treatment process and clinical feedback researchers may evaluate the sensitiveness and specificity of PTC drug screening technique in predicting clinical outcome for advanced malignancy patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None